Month: June 2025

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) — Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today announced that Cris Keirn, Chief Executive Officer, and Mark Weinswig, Chief Financial Officer, will virtually participate in the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference, on June 9-11. Chief Executive Officer Cris Keirn will host a fireside chat on Tuesday, June 10 at 11:15a.m. ET, and management will also be available for meetings during the conference. A live webcast of the event will be available through the “Events & Presentations” section of TBCH’s website at corp.turtlebeach.com. A replay of the webcast will be available on the investor relations website for 90 days. About Turtle Beach CorporationTurtle Beach Corporation (the “Company”) (corp.turtlebeach.com) is one...

MORRISTOWN, N.J., June 06, 2025 (GLOBE NEWSWIRE) — via IBN — Maybacks Global Entertainment, LLC, a wholly owned subsidiary of Authentic Holdings, Inc. (OTC:AHRO), has signed a Licensing and Distribution Agreement with Plex GmbH (“Plex”). Maureen Cooper, Sr VP and Program Director of Maybacks, stated: “We are excited to announce a strategic licensing and distribution agreement with Plex. This partnership marks a significant milestone in Maybacks’ ongoing efforts to expand its distribution footprint and strengthen its network brands.” Following the acquisition of Goliath Motion Picture Promotions (“Goliath”), Maybacks has significantly broadened its access to greater distribution opportunities and innovative revenue models. While Goliath primarily focused on film sales, successfully...

AUSTIN, Texas, June 06, 2025 (GLOBE NEWSWIRE) — via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled ” Next Gold Powerhouse Emerges as Prices Break Records,” featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF). To hear the NetworkNewsAudio version, visit LINK To read the original editorial, visit LINK Earlier this year, ESGold closed on C$3.45 million financing earmarked to advance its Montauban Project toward production. This successful closing marked a pivotal point for the company, providing the necessary capital to initiate mill circuit construction and mobilize the final phase of development at Montauban. Located in Quebec, Montauban is a past-producing gold-silver mine with surface and underground mineralization and more than 900,000 tons of historical tailings. With much of the funding in place,...

Joint Venture Represents First Major Step in U.S.-Based Manufacturing RANCHO CUCAMONGA, Calif., June 06, 2025 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced the formation of United Package NV LLC (“United Package”), a new joint venture (“JV”) that marks the first full-scale implementation of its “Made in USA” module within the Company’s proprietary SuperSuite Supply Chain Platform. This milestone represents iPower’s commitment to building a resilient, localized manufacturing infrastructure in the United States. United Package will focus on the domestic production of packaging materials to serve the rapidly growing demands of U.S. businesses seeking reliable, sustainable, and cost-effective supply chain solutions without...

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that the Company has issued additional shares of its Series D Preferred Stock to certain institutional investors (the “Investors”) pursuant to the securities purchase agreement previously entered into by and between the Company and such Investors on April 22, 2025 with respect to the issuance of shares of Series D Preferred Stock for an aggregate purchase price of up to $8 million, including $5 million previously issued in April 2025 and up to $3 million issuable at the option of the Investors. The shares of Series D Preferred Stock are convertible into shares...

Appointment of seasoned strategic industry executive strengthens the Board of Directors as Candel advances toward Biologics License Application submission and commercial development NEEDHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Maha Radhakrishnan, M.D., to the Company’s Board of Directors (Board) effective June 4, 2025. “We are delighted to welcome Maha as a new member of Candel’s Board,” said Paul Peter Tak, M.D., Ph.D., FMedSci, President and Chief Executive Officer of Candel. “Her extensive industry experience will be extremely valuable as Candel advances its late-stage oncology programs toward...

COCONUT CREEK, Fla., June 06, 2025 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today that its wholly-owned subsidiary, Willis Engine Structured Trust VIII (“WEST”), has priced $524,000,000 in aggregate principal amount of Series A Fixed Rate Notes (the “Series A Notes”) and $72,000,000 in aggregate principal amount of Series B Fixed Rate Notes (the “Series B Notes” and, together with the Series A Notes, the “Notes”). The Notes will be secured by, among other things, WEST’s direct and indirect interests in a portfolio of 62 aircraft engines and two airframes, which WEST will acquire from WLFC or its other subsidiaries pursuant to an asset purchase agreement. The planned closing date...

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. “We are excited to welcome Denice to the Celldex Board of Directors,” said Anthony Marucci, Co-founder, President and Chief Executive Officer of Celldex. “Denice’s extensive leadership experience across both the pharmaceutical and consumer healthcare sectors brings a deep operational and commercial perspective to our team. Her track record of driving strategic growth and operational excellence will be instrumental as we advance our clinical programs and continue building our organization.” Ms. Torres added, “I am thrilled to join the board of Celldex, particularly at this exciting time in the Company’s development. I am...